Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold

In Australia, cystic fibrosis (CF) causes severe impairments to a person’s lungs, airways and digestive system. World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin , increasing its efficacy by up to...